88 related articles for article (PubMed ID: 24074562)
21. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.
Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR
J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520
[TBL] [Abstract][Full Text] [Related]
22. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress.
Jeon SM; Chandel NS; Hay N
Nature; 2012 May; 485(7400):661-5. PubMed ID: 22660331
[TBL] [Abstract][Full Text] [Related]
23. Cancer associated human papillomaviruses.
McLaughlin-Drubin ME; Meyers J; Munger K
Curr Opin Virol; 2012 Aug; 2(4):459-66. PubMed ID: 22658985
[TBL] [Abstract][Full Text] [Related]
24. Deregulated MYC expression induces dependence upon AMPK-related kinase 5.
Liu L; Ulbrich J; Müller J; Wüstefeld T; Aeberhard L; Kress TR; Muthalagu N; Rycak L; Rudalska R; Moll R; Kempa S; Zender L; Eilers M; Murphy DJ
Nature; 2012 Mar; 483(7391):608-12. PubMed ID: 22460906
[TBL] [Abstract][Full Text] [Related]
25. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.
Namiki T; Tanemura A; Valencia JC; Coelho SG; Passeron T; Kawaguchi M; Vieira WD; Ishikawa M; Nishijima W; Izumo T; Kaneko Y; Katayama I; Yamaguchi Y; Yin L; Polley EC; Liu H; Kawakami Y; Eishi Y; Takahashi E; Yokozeki H; Hearing VJ
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6597-602. PubMed ID: 21460252
[TBL] [Abstract][Full Text] [Related]
26. Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.
Emmanuel C; Gava N; Kennedy C; Balleine RL; Sharma R; Wain G; Brand A; Hogg R; Etemadmoghadam D; George J; ; Birrer MJ; Clarke CL; Chenevix-Trench G; Bowtell DD; Harnett PR; deFazio A
PLoS One; 2011 Mar; 6(3):e17617. PubMed ID: 21423607
[TBL] [Abstract][Full Text] [Related]
27. Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.
Castro FA; Ivansson EL; Schmitt M; Juko-Pecirep I; Kjellberg L; Hildesheim A; Gyllensten UB; Pawlita M
Int J Cancer; 2012 Jan; 130(2):349-55. PubMed ID: 21387292
[TBL] [Abstract][Full Text] [Related]
28. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation.
Hou X; Liu JE; Liu W; Liu CY; Liu ZY; Sun ZY
Oncogene; 2011 Jun; 30(26):2933-42. PubMed ID: 21317932
[TBL] [Abstract][Full Text] [Related]
29. HPV - immune response to infection and vaccination.
Stanley M
Infect Agent Cancer; 2010 Oct; 5():19. PubMed ID: 20961432
[TBL] [Abstract][Full Text] [Related]
30. Peutz-Jeghers syndrome: a systematic review and recommendations for management.
Beggs AD; Latchford AR; Vasen HF; Moslein G; Alonso A; Aretz S; Bertario L; Blanco I; Bülow S; Burn J; Capella G; Colas C; Friedl W; Møller P; Hes FJ; Järvinen H; Mecklin JP; Nagengast FM; Parc Y; Phillips RK; Hyer W; Ponz de Leon M; Renkonen-Sinisalo L; Sampson JR; Stormorken A; Tejpar S; Thomas HJ; Wijnen JT; Clark SK; Hodgson SV
Gut; 2010 Jul; 59(7):975-86. PubMed ID: 20581245
[TBL] [Abstract][Full Text] [Related]
31. New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion.
Zagórska A; Deak M; Campbell DG; Banerjee S; Hirano M; Aizawa S; Prescott AR; Alessi DR
Sci Signal; 2010 Mar; 3(115):ra25. PubMed ID: 20354225
[TBL] [Abstract][Full Text] [Related]
32. Common genetic variants and risk for HPV persistence and progression to cervical cancer.
Wang SS; Gonzalez P; Yu K; Porras C; Li Q; Safaeian M; Rodriguez AC; Sherman ME; Bratti C; Schiffman M; Wacholder S; Burk RD; Herrero R; Chanock SJ; Hildesheim A
PLoS One; 2010 Jan; 5(1):e8667. PubMed ID: 20084279
[TBL] [Abstract][Full Text] [Related]
33. Glucose deprivation-induced metabolic oxidative stress and cancer therapy.
Simons AL; Mattson DM; Dornfeld K; Spitz DR
J Cancer Res Ther; 2009 Sep; 5 Suppl 1(Suppl 1):S2-6. PubMed ID: 20009288
[TBL] [Abstract][Full Text] [Related]
34. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1.
Humbert N; Navaratnam N; Augert A; Da Costa M; Martien S; Wang J; Martinez D; Abbadie C; Carling D; de Launoit Y; Gil J; Bernard D
EMBO J; 2010 Jan; 29(2):376-86. PubMed ID: 19927127
[TBL] [Abstract][Full Text] [Related]
35. SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.
Cheng H; Liu P; Wang ZC; Zou L; Santiago S; Garbitt V; Gjoerup OV; Iglehart JD; Miron A; Richardson AL; Hahn WC; Zhao JJ
Sci Signal; 2009 Jul; 2(80):ra35. PubMed ID: 19622832
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
Yu SY; Chan DW; Liu VW; Ngan HY
Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
[TBL] [Abstract][Full Text] [Related]
37. Somatic LKB1 mutations promote cervical cancer progression.
Wingo SN; Gallardo TD; Akbay EA; Liang MC; Contreras CM; Boren T; Shimamura T; Miller DS; Sharpless NE; Bardeesy N; Kwiatkowski DJ; Schorge JO; Wong KK; Castrillon DH
PLoS One; 2009; 4(4):e5137. PubMed ID: 19340305
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation.
Zheng B; Jeong JH; Asara JM; Yuan YY; Granter SR; Chin L; Cantley LC
Mol Cell; 2009 Jan; 33(2):237-47. PubMed ID: 19187764
[TBL] [Abstract][Full Text] [Related]
39. LKB1; linking cell structure and tumor suppression.
Hezel AF; Bardeesy N
Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
[TBL] [Abstract][Full Text] [Related]
40. A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth.
Ralser M; Wamelink MM; Struys EA; Joppich C; Krobitsch S; Jakobs C; Lehrach H
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17807-11. PubMed ID: 19004802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]